long term oral treatment with acebutolol protected against postischaemic ventricular fibrillation and significantly reduced the incidence of both early phase ( 0-10 min postocclusion ) ventricular arrhythmias and ventricular fibrillation .
C0000946
acebutolol
C0042510
ventricular fibrillation